Recent News for GEMP - Gemphire Therapeutics Inc.

Date Title
Oct 11 The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
Oct 2 The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
Sep 27 The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
Sep 26 The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J
Sep 10 The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris
Aug 20 Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster
Aug 20 22 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Aug 16 The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission
Aug 9 31 Healthcare Stocks Moving In Today's Pre-Market Session
Aug 9 Gemphire Therapeutics EPS misses by $0.08
Aug 9 Gemphire Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Aug 3 29 Healthcare Stocks Moving In Friday's After-Market Session
Jul 31 Gemphire And Gemcabene: Closure And The End
Jul 26 A Look At Benzinga Pro's Most-Searched Tickers For July 26, 2019
Jul 25 Mid-Day Market Update: Dow Down 170 Points; Gemphire Therapeutics Shares Spike Higher
Jul 25 Gemphire Flirts With $1 Level As Struggling Biotech Strikes Reverse Merger Deal
Jul 25 The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug
Jul 25 35 Healthcare Stocks Moving In Wednesday's After-Market Session
Jul 24 Gemphire to combine with NeuroBo in reverse merger
Jul 24 Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
Jun 27 Gemphire Therapeutics Inc.'s (NASDAQ:GEMP) Path To Profitability
Jun 26 Mid-Afternoon Market Update: Micron Technology Jumps On Upbeat Q3 Results; OncoCyte Shares Slide
Jun 26 Gemphire Therapeutics Falls 20% After Oral Cholesterol Drug Trial Results
Jun 26 INO, XSPA, EROS and GBT among midday movers
Jun 26 Mid-Day Market Update: Crude Oil Up 2.9%; Gemphire Therapeutics Shares Plummet
Back to the Main GEMP Page...